Page last updated: 2024-08-16

thalidomide and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

thalidomide has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cronstein, B; Mediero, A; Montesinos, MC; Perez-Aso, M; Schafer, PH; Wilder, T1

Other Studies

1 other study(ies) available for thalidomide and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

ArticleYear
Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors.
    Arthritis research & therapy, 2015, Sep-15, Volume: 17

    Topics: Adenosine; Animals; Antirheumatic Agents; Blotting, Western; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytokines; Gene Expression; Guanine Nucleotide Exchange Factors; Inflammation Mediators; Macrophages; Male; Methotrexate; Mice; Phenethylamines; Phosphodiesterase 4 Inhibitors; Receptor, Adenosine A2A; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Thalidomide; Tumor Necrosis Factor-alpha

2015